ROIV ROIVANT SCIENCES LTD More: the full row for ROIVANT SCIENCES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 150,000 shares; 2025Q2: 400,000 shares; 2025Q3: 800,000 shares; 2025Q4: 1,700,000 shares; 2026Q1: 2,800,000 shares; 2026Q2: 3,750,000 shares; 2026Q3: 3,200,000 shares 3,200,000 $117M 6.64% -550,000 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 824,328 shares; 2025Q1: 481,678 shares; 2025Q2: 606,678 shares; 2025Q3: 1,419,299 shares; 2025Q4: 1,432,591 shares; 2026Q1: 1,279,134 shares; 2026Q2: 1,279,134 shares; 2026Q3: 1,279,134 shares 1,279,134 $114M 6.46% 0 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,499,431 shares; 2025Q1: 3,341,519 shares; 2025Q2: 4,085,787 shares; 2025Q3: 4,285,787 shares; 2025Q4: 3,900,000 shares; 2026Q1: 5,350,000 shares; 2026Q2: 5,250,000 shares; 2026Q3: 5,590,600 shares 5,590,600 $82M 4.65% +340,600 Timeline TRAX FIRST TRACKS BIOTHERAPEUTICS More: the full row for FIRST TRACKS BIOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,032,012 shares; 2026Q3: 2,080,000 shares 2,080,000 $73.7M 4.18% +47,988 Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,161,237 shares; 2025Q1: 1,328,175 shares; 2025Q2: 1,100,000 shares; 2025Q3: 1,400,000 shares; 2025Q4: 1,250,000 shares; 2026Q1: 1,675,000 shares; 2026Q2: 1,595,000 shares; 2026Q3: 1,900,374 shares 1,900,374 $70.7M 4.01% +305,374 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 50,000 shares; 2025Q1: 140,000 shares; 2025Q2: 475,000 shares; 2025Q3: 450,000 shares; 2025Q4: 450,000 shares; 2026Q1: 480,000 shares; 2026Q2: 650,000 shares; 2026Q3: 564,251 shares 564,251 $64.4M 3.65% -85,749 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,100,000 shares; 2025Q1: 1,000,000 shares; 2025Q2: 1,000,000 shares; 2025Q3: 1,250,000 shares; 2025Q4: 1,000,000 shares; 2026Q1: 1,350,000 shares; 2026Q2: 1,125,000 shares; 2026Q3: 1,565,000 shares 1,565,000 $63.4M 3.6% +440,000 Timeline ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 368,698 shares; 2025Q1: 545,362 shares; 2025Q2: 603,479 shares; 2025Q3: 959,180 shares; 2025Q4: 802,342 shares; 2026Q1: 499,673 shares; 2026Q2: 590,000 shares; 2026Q3: 600,000 shares 600,000 $50M 2.83% +10,000 Timeline AVTX AVALO THERAPEUTICS INC More: the full row for AVALO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 550,765 shares; 2025Q1: 657,154 shares; 2025Q2: 607,872 shares; 2025Q3: 1,006,217 shares; 2025Q4: 1,051,054 shares; 2026Q1: 1,340,840 shares; 2026Q2: 2,900,000 shares; 2026Q3: 3,244,861 shares 3,244,861 $49.7M 2.82% +344,861 Timeline CYTK CYTOKINETICS INC More: the full row for CYTOKINETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 350,000 shares; 2025Q4: 800,000 shares; 2026Q1: 700,483 shares; 2026Q2: 550,000 shares; 2026Q3: 750,000 shares 750,000 $49.4M 2.8% +200,000 Timeline RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares; 2026Q2: 250,000 shares; 2026Q3: 225,000 shares 225,000 $46.2M 2.62% -25,000 Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 185,000 shares; 2026Q1: 170,000 shares; 2026Q2: 185,000 shares; 2026Q3: 155,000 shares 155,000 $45.1M 2.56% -30,000 Timeline BLTE BELITE BIO INC More: the full row for BELITE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 65,000 shares; 2026Q2: 165,000 shares; 2026Q3: 242,088 shares 242,088 $41.1M 2.33% +77,088 Timeline CLDX CELLDEX THERAPEUTICS INC NEW More: the full row for CELLDEX THERAPEUTICS INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,992 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 350,000 shares; 2026Q1: 500,000 shares; 2026Q2: 700,000 shares; 2026Q3: 1,160,499 shares 1,160,499 $37.6M 2.13% +460,499 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 200,000 shares; 2025Q2: 100,000 shares; 2025Q3: 360,000 shares; 2025Q4: 505,000 shares; 2026Q1: 405,000 shares; 2026Q2: 330,000 shares; 2026Q3: 330,000 shares 330,000 $32.7M 1.85% 0 Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 262,100 shares; 2025Q4: 115,000 shares; 2026Q1: 350,000 shares; 2026Q2: 400,000 shares; 2026Q3: 350,000 shares 350,000 $30.8M 1.75% -50,000 Timeline ODTX ODYSSEY THERAPEUTICS INC More: the full row for ODYSSEY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 766,346 shares; 2026Q3: 1,260,000 shares 1,260,000 $28M 1.59% +493,654 Timeline ARWR ARROWHEAD PHARMACEUTICALS IN More: the full row for ARROWHEAD PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 70,000 shares; 2026Q1: 200,000 shares; 2026Q2: 150,000 shares; 2026Q3: 425,000 shares 425,000 $27.8M 1.58% +275,000 Timeline TRVI TREVI THERAPEUTICS INC More: the full row for TREVI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,250,000 shares; 2025Q2: 2,534,058 shares; 2025Q3: 2,800,000 shares; 2025Q4: 2,150,172 shares; 2026Q1: 2,000,172 shares; 2026Q2: 1,800,172 shares; 2026Q3: 1,800,172 shares 1,800,172 $25.8M 1.46% 0 Timeline OVID OVID THERAPEUTICS INC More: the full row for OVID THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 667,516 shares; 2025Q2: 667,516 shares; 2025Q3: 2,650,000 shares; 2025Q4: 7,150,000 shares; 2026Q1: 10,636,318 shares; 2026Q2: 10,144,562 shares; 2026Q3: 10,144,562 shares 10,144,562 $25.3M 1.43% 0 Timeline SGMT SAGIMET BIOSCIENCES INC More: the full row for SAGIMET BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 350,000 shares; 2025Q4: 1,148,245 shares; 2026Q1: 868,020 shares; 2026Q2: 2,497,864 shares; 2026Q3: 2,527,384 shares 2,527,384 $25M 1.42% +29,520 Timeline LXEO LEXEO THERAPEUTICS INC More: the full row for LEXEO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,480,881 shares; 2025Q2: 3,589,355 shares; 2025Q3: 3,870,527 shares; 2025Q4: 3,200,000 shares; 2026Q1: 5,050,211 shares; 2026Q2: 5,807,611 shares; 2026Q3: 7,245,611 shares 7,245,611 $24.5M 1.39% +1,438,000 Timeline PTGX PROTAGONIST THERAPEUTICS INC More: the full row for PROTAGONIST THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 130,000 shares; 2025Q1: 400,000 shares; 2025Q2: 440,000 shares; 2025Q3: 220,600 shares; 2025Q4: 172,125 shares; 2026Q1: 172,125 shares; 2026Q2: 172,125 shares; 2026Q3: 172,125 shares 172,125 $24.3M 1.38% 0 Timeline NRIX NURIX THERAPEUTICS INC More: the full row for NURIX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 940,083 shares; 2025Q1: 810,669 shares; 2025Q2: 967,620 shares; 2025Q3: 967,620 shares; 2025Q4: 967,620 shares; 2026Q1: 967,620 shares; 2026Q2: 967,620 shares; 2026Q3: 967,620 shares 967,620 $22.9M 1.3% 0 Timeline VOGX VOGENX INC More: the full row for VOGENX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 915,000 shares 915,000 $20.9M 1.18% new Timeline MLYS MINERALYS THERAPEUTICS INC More: the full row for MINERALYS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 350,000 shares; 2025Q1: 1,100,000 shares; 2025Q2: 900,000 shares; 2025Q3: 750,000 shares; 2025Q4: 730,000 shares; 2026Q1: 750,000 shares; 2026Q2: 750,000 shares; 2026Q3: 750,000 shares 750,000 $18.8M 1.07% 0 Timeline TYRA TYRA BIOSCIENCES INC More: the full row for TYRA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 257,512 shares; 2026Q2: 200,012 shares; 2026Q3: 850,000 shares 850,000 $18.6M 1.05% +649,988 Timeline STRO SUTRO BIOPHARMA INC More: the full row for SUTRO BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 748,382 shares; 2026Q1: 1,069,519 shares; 2026Q2: 1,172,487 shares; 2026Q3: 1,152,487 shares 1,152,487 $18.6M 1.05% -20,000 Timeline TVTX TRAVERE THERAPEUTICS INC More: the full row for TRAVERE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 200,000 shares; 2025Q1: 1,070,000 shares; 2025Q2: 970,000 shares; 2025Q3: 500,000 shares; 2025Q4: 300,000 shares; 2026Q1: 300,000 shares; 2026Q2: 300,000 shares; 2026Q3: 300,000 shares 300,000 $17.7M 1% 0 Timeline ANRO ALTO NEUROSCIENCE INC More: the full row for ALTO NEUROSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 500,000 shares; 2026Q2: 850,000 shares; 2026Q3: 643,343 shares 643,343 $16.4M 0.93% -206,657 Timeline ARVN ARVINAS INC More: the full row for ARVINAS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 630,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,050,000 shares 2,050,000 $15.9M 0.9% new Timeline EPRX EUPRAXIA PHARMACEUTICALS INC More: the full row for EUPRAXIA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares; 2026Q1: 1,589,005 shares; 2026Q2: 1,650,000 shares; 2026Q3: 1,716,320 shares 1,716,320 $15.6M 0.89% +66,320 Timeline RLAY RELAY THERAPEUTICS INC More: the full row for RELAY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 400,000 shares; 2026Q2: 1,050,000 shares; 2026Q3: 850,000 shares 850,000 $15.3M 0.87% -200,000 Timeline MDGL MADRIGAL PHARMACEUTICALS INC More: the full row for MADRIGAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 82,500 shares; 2025Q1: 80,000 shares; 2025Q2: 80,000 shares; 2025Q3: 115,000 shares; 2025Q4: 31,131 shares; 2026Q1: 55,000 shares; 2026Q2: 40,000 shares; 2026Q3: 30,000 shares 30,000 $15.1M 0.86% -10,000 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 263,817 shares; 2025Q1: 263,817 shares; 2025Q2: 263,817 shares; 2025Q3: 263,817 shares; 2025Q4: 1,932,106 shares; 2026Q1: 781,260 shares; 2026Q2: 875,760 shares; 2026Q3: 875,760 shares 875,760 $13.4M 0.76% 0 Timeline SVRA SAVARA INC More: the full row for SAVARA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 410,586 shares; 2025Q1: not reported; 2025Q2: 500,000 shares; 2025Q3: 1,500,000 shares; 2025Q4: 2,797,153 shares; 2026Q1: 2,512,153 shares; 2026Q2: 2,512,153 shares; 2026Q3: 2,512,153 shares 2,512,153 $13M 0.74% 0 Timeline COAG HEMAB THERAPEUTICS HLDGS INC More: the full row for HEMAB THERAPEUTICS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 138,030 shares; 2026Q3: 420,000 shares 420,000 $13M 0.73% +281,970 Timeline CLYM CLIMB BIO INC More: the full row for CLIMB BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,000 shares; 2025Q1: 1,500,000 shares; 2025Q2: 1,500,000 shares; 2025Q3: 1,300,000 shares; 2025Q4: 1,300,000 shares; 2026Q1: 700,000 shares; 2026Q2: 972,000 shares; 2026Q3: 972,000 shares 972,000 $11.1M 0.63% 0 Timeline IBRX IMMUNITYBIO INC More: the full row for IMMUNITYBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,180,000 shares 1,180,000 $11.1M 0.63% new Timeline BEAM BEAM THERAPEUTICS INC More: the full row for BEAM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000 $11M 0.62% new Timeline CATX PERSPECTIVE THERAPEUTICS INC More: the full row for PERSPECTIVE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,300,000 shares; 2025Q1: 2,224,196 shares; 2025Q2: 1,050,000 shares; 2025Q3: 300,000 shares; 2025Q4: 300,000 shares; 2026Q1: 3,164,582 shares; 2026Q2: 4,214,582 shares; 2026Q3: 3,988,744 shares 3,988,744 $11M 0.62% -225,838 Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 65,317 shares; 2025Q3: 65,317 shares; 2025Q4: 714,956 shares; 2026Q1: 639,956 shares; 2026Q2: 840,350 shares; 2026Q3: 760,350 shares 760,350 $10.7M 0.61% -80,000 Timeline PRLD PRELUDE THERAPEUTICS INC More: the full row for PRELUDE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,600,000 shares 2,600,000 $10.2M 0.58% new Timeline CRSP CRISPR THERAPEUTICS AG More: the full row for CRISPR THERAPEUTICS AG Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 150,000 shares; 2026Q2: 100,000 shares; 2026Q3: 175,000 shares 175,000 $9.68M 0.55% +75,000 Timeline MANE VERADERMICS INC More: the full row for VERADERMICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 70,000 shares; 2026Q2: 100,000 shares; 2026Q3: 79,400 shares 79,400 $9.63M 0.55% -20,600 Timeline ESTA ESTABLISHMENT LABS HLDGS INC More: the full row for ESTABLISHMENT LABS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 279,445 shares; 2025Q1: 280,000 shares; 2025Q2: 334,863 shares; 2025Q3: 310,000 shares; 2025Q4: 200,000 shares; 2026Q1: 100,000 shares; 2026Q2: 148,013 shares; 2026Q3: 149,779 shares 149,779 $9.61M 0.55% +1,766 Timeline AMLX AMYLYX PHARMACEUTICALS INC More: the full row for AMYLYX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 98,999 shares; 2026Q3: 300,000 shares 300,000 $8.73M 0.5% +201,001 Timeline KRSA KORSANA BIOSCIENCES INC More: the full row for KORSANA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 263,106 shares 263,106 $8.42M 0.48% new Timeline PRQR PROQR THRAPEUTICS N V More: the full row for PROQR THRAPEUTICS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,825,000 shares; 2025Q1: 3,284,512 shares; 2025Q2: 3,499,512 shares; 2025Q3: 3,600,000 shares; 2025Q4: 2,454,278 shares; 2026Q1: 2,454,278 shares; 2026Q2: 5,543,936 shares; 2026Q3: 4,970,074 shares 4,970,074 $8.25M 0.47% -573,862 Timeline VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 425,000 shares; 2025Q1: 355,143 shares; 2025Q2: 545,000 shares; 2025Q3: 303,330 shares; 2025Q4: 250,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000 $8.07M 0.46% 0 Timeline DMRA DAMORA THERAPEUTICS INC More: the full row for DAMORA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 375,000 shares 375,000 $7.98M 0.45% new Timeline RACC RESEARCH ALLIANCE CORP III More: the full row for RESEARCH ALLIANCE CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 370,000 shares; 2026Q3: 735,538 shares 735,538 $7.97M 0.45% +365,538 Timeline SLGL SOL-GEL TECHNOLOGIES LTD More: the full row for SOL-GEL TECHNOLOGIES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 35,000 shares; 2026Q2: 84,900 shares; 2026Q3: 105,000 shares 105,000 $7.8M 0.44% +20,100 Timeline IDYA IDEAYA BIOSCIENCES INC More: the full row for IDEAYA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 400,000 shares; 2026Q3: 200,000 shares 200,000 $7.68M 0.44% -200,000 Timeline AVR ANTERIS TECHNOLOGIES GLOBAL More: the full row for ANTERIS TECHNOLOGIES GLOBAL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 300,000 shares; 2025Q1: 390,000 shares; 2025Q2: 425,000 shares; 2025Q3: 450,000 shares; 2025Q4: 486,684 shares; 2026Q1: 912,397 shares; 2026Q2: 912,397 shares; 2026Q3: 912,397 shares 912,397 $7.09M 0.4% 0 Timeline AKTS AKTIS ONCOLOGY INC More: the full row for AKTIS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 350,000 shares 350,000 $6.81M 0.39% new Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 400,000 shares; 2025Q3: 400,000 shares; 2025Q4: not reported; 2026Q1: 586,904 shares; 2026Q2: 500,000 shares; 2026Q3: 148,000 shares 148,000 $6.78M 0.38% -352,000 Timeline NAMS NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 425,000 shares; 2025Q1: 325,000 shares; 2025Q2: 275,000 shares; 2025Q3: 275,000 shares; 2025Q4: 275,000 shares; 2026Q1: 275,000 shares; 2026Q2: 275,000 shares; 2026Q3: 275,000 shares 275,000 $6.69M 0.38% 0 Timeline HLXC HELIX ACQUISITION CORP III More: the full row for HELIX ACQUISITION CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,250,000 shares; 2026Q2: 1,250,000 shares; 2026Q3: 625,000 shares 625,000 $6.64M 0.38% -625,000 Timeline XFOR X4 PHARMACEUTICALS INC More: the full row for X4 PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 145,000 shares; 2026Q1: 145,000 shares; 2026Q2: 145,000 shares; 2026Q3: 2,062,500 shares 2,062,500 $5.98M 0.34% +1,917,500 Timeline KRRO KORRO BIO INC More: the full row for KORRO BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 706,904 shares; 2026Q2: 706,904 shares; 2026Q3: 531,904 shares 531,904 $5.27M 0.3% -175,000 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 159,614 shares; 2025Q1: 390,000 shares; 2025Q2: 390,000 shares; 2025Q3: 250,000 shares; 2025Q4: 250,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000 $5.15M 0.29% 0 Timeline SLN SILENCE THERAPEUTICS PLC More: the full row for SILENCE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 450,000 shares 450,000 $4.92M 0.28% new Timeline IBIO IBIO INC More: the full row for IBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,057,200 shares; 2026Q1: 3,107,200 shares; 2026Q2: 4,007,881 shares; 2026Q3: 4,130,427 shares 4,130,427 $4.87M 0.28% +122,546 Timeline TSHA TAYSHA GENE THERAPIES INC More: the full row for TAYSHA GENE THERAPIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 200,000 shares; 2025Q3: 3,000,000 shares; 2025Q4: 3,300,000 shares; 2026Q1: 1,000,000 shares; 2026Q2: 1,750,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $4.87M 0.28% -750,000 Timeline SABS SAB BIOTHERAPEUTICS INC More: the full row for SAB BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 575,000 shares; 2026Q2: 1,525,000 shares; 2026Q3: 1,525,000 shares 1,525,000 $4.83M 0.27% 0 Timeline IRD OPUS GENETICS INC More: the full row for OPUS GENETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 900,000 shares 900,000 $4.36M 0.25% new Timeline FTH FAETH THERAPEUTICS INC More: the full row for FAETH THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 144,404 shares; 2026Q3: 144,404 shares 144,404 $4.29M 0.24% 0 Timeline EQ EQUILLIUM INC More: the full row for EQUILLIUM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,226,310 shares; 2026Q2: 4,100,000 shares; 2026Q3: 2,613,954 shares 2,613,954 $4.25M 0.24% -1,486,046 Timeline NTLA INTELLIA THERAPEUTICS INC More: the full row for INTELLIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 350,000 shares 350,000 $4.22M 0.24% new Timeline LTGO LATIGO BIOTHERAPEUTICS INC More: the full row for LATIGO BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 250,000 shares 250,000 $4.17M 0.24% new Timeline RZLT REZOLUTE INC More: the full row for REZOLUTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,575,000 shares; 2025Q1: 1,700,000 shares; 2025Q2: 2,200,000 shares; 2025Q3: 2,100,000 shares; 2025Q4: 2,351,144 shares; 2026Q1: 1,547,641 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000 $4.14M 0.23% 0 Timeline ARKG ARK ETF TR More: the full row for ARK ETF TR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 74,900 shares 74,900 $4.06M 0.23% new Timeline DTIL PRECISION BIOSCIENCES INC More: the full row for PRECISION BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 597,946 shares; 2026Q2: 646,576 shares; 2026Q3: 646,576 shares 646,576 $4.05M 0.23% 0 Timeline AMAN AMANAT ACQUISITION CORP More: the full row for AMANAT ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 375,000 shares; 2026Q3: 375,000 shares 375,000 $4M 0.23% 0 Timeline CMPS COMPASS PATHWAYS PLC More: the full row for COMPASS PATHWAYS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 850,512 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,000 shares; 2025Q4: 200,000 shares; 2026Q1: 1,108,483 shares; 2026Q2: 301,183 shares; 2026Q3: 301,183 shares 301,183 $3.75M 0.21% 0 Timeline RNAQU RAINIER ACQUISITION CORP More: the full row for RAINIER ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 364,957 shares 364,957 $3.72M 0.21% new Timeline MGNX MACROGENICS INC More: the full row for MACROGENICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 484,308 shares; 2026Q1: 500,000 shares; 2026Q2: 1,216,606 shares; 2026Q3: 953,979 shares 953,979 $3.68M 0.21% -262,627 Timeline RACD RESEARCH ALLIANCE CORP IV More: the full row for RESEARCH ALLIANCE CORP IV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $3.6M 0.2% new Timeline IMVT IMMUNOVANT INC More: the full row for IMMUNOVANT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 100,000 shares; 2025Q1: 430,000 shares; 2025Q2: not reported; 2025Q3: 300,000 shares; 2025Q4: 200,000 shares; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 100,000 shares 100,000 $3.38M 0.19% 0 Timeline ANAB ANAPTYSBIO INC More: the full row for ANAPTYSBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 444,692 shares; 2026Q1: 940,000 shares; 2026Q2: 826,109 shares; 2026Q3: 66,464 shares 66,464 $3.34M 0.19% -759,645 Timeline ZURA ZURA BIO LTD More: the full row for ZURA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 223,335 shares; 2025Q1: 223,335 shares; 2025Q2: 223,335 shares; 2025Q3: 1,274,351 shares; 2025Q4: 1,813,671 shares; 2026Q1: 2,564,303 shares; 2026Q2: 1,464,303 shares; 2026Q3: 800,000 shares 800,000 $3.33M 0.19% -664,303 Timeline NAMSW NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 237,935 shares; 2025Q1: 241,957 shares; 2025Q2: 245,000 shares; 2025Q3: 245,000 shares; 2025Q4: 245,000 shares; 2026Q1: 245,000 shares; 2026Q2: 245,000 shares; 2026Q3: 245,000 shares 245,000 $3.31M 0.19% 0 Timeline VRCA VERRICA PHARMACEUTICALS INC More: the full row for VERRICA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 707,338 shares; 2026Q1: 707,338 shares; 2026Q2: 707,338 shares; 2026Q3: 688,654 shares 688,654 $3.3M 0.19% -18,684 Timeline AVBP ARRIVENT BIOPHARMA INC More: the full row for ARRIVENT BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 150,000 shares; 2026Q1: 175,000 shares; 2026Q2: 125,000 shares; 2026Q3: 100,000 shares 100,000 $3.03M 0.17% -25,000 Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 175,000 shares; 2025Q2: not reported; 2025Q3: 165,000 shares; 2025Q4: 250,000 shares; 2026Q1: 150,000 shares; 2026Q2: 75,000 shares; 2026Q3: 50,000 shares 50,000 $2.93M 0.17% -25,000 Timeline PMVP PMV PHARMACEUTICALS INC More: the full row for PMV PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,750,000 shares 1,750,000 $2.92M 0.17% new Timeline SLDB SOLID BIOSCIENCES INC More: the full row for SOLID BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 400,000 shares 400,000 $2.89M 0.16% new Timeline OACCU OAKTREE ACQUISITION CORP III More: the full row for OAKTREE ACQUISITION CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 250,000 shares; 2025Q1: 250,000 shares; 2025Q2: 250,000 shares; 2025Q3: 250,000 shares; 2025Q4: 250,000 shares; 2026Q1: 250,000 shares; 2026Q2: 250,000 shares; 2026Q3: 250,000 shares 250,000 $2.72M 0.15% 0 Timeline ENTX ENTERA BIO LTD More: the full row for ENTERA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 934,412 shares 934,412 $2.72M 0.15% new Timeline NMRA NEUMORA THERAPEUTICS INC. More: the full row for NEUMORA THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,070,651 shares; 2026Q3: 4,500,000 shares 4,500,000 $2.68M 0.15% +3,429,349 Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000 $2.5M 0.14% new Timeline ANL ADLAI NORTYE GROUP LTD More: the full row for ADLAI NORTYE GROUP LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 164,748 shares; 2026Q2: 153,847 shares; 2026Q3: 153,847 shares 153,847 $2.46M 0.14% 0 Timeline EIKN EIKON THERAPEUTICS INC More: the full row for EIKON THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 98,001 shares; 2026Q3: 298,001 shares 298,001 $2.4M 0.14% +200,000 Timeline JTTT JATT III ACQUISITION CORP More: the full row for JATT III ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 211,993 shares 211,993 $2.34M 0.13% new Timeline JATT JATT II ACQUISITION CORP More: the full row for JATT II ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000 $2.25M 0.13% 0 Timeline SPRO SPERO THERAPEUTICS INC More: the full row for SPERO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,300,000 shares 1,300,000 $1.57M 0.09% new Timeline GENB GENERATE BIOMEDICINES INC More: the full row for GENERATE BIOMEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 350,000 shares; 2026Q2: 400,000 shares; 2026Q3: 100,000 shares 100,000 $1.5M 0.09% -300,000 Timeline NXTC NEXTCURE INC More: the full row for NEXTCURE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 191,882 shares; 2025Q4: 247,294 shares; 2026Q1: 241,826 shares; 2026Q2: 41,960 shares; 2026Q3: 291,960 shares 291,960 $1.46M 0.08% +250,000 Timeline LENZ LENZ THERAPEUTICS INC More: the full row for LENZ THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares; 2026Q2: 100,000 shares; 2026Q3: 300,000 shares 300,000 $1.15M 0.07% +200,000 Timeline JSPR JASPER THERAPEUTICS INC More: the full row for JASPER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,850,000 shares 1,850,000 $1.07M 0.06% new Timeline FDMT 4D MOLECULAR THERAPEUTICS IN More: the full row for 4D MOLECULAR THERAPEUTICS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000 $716K 0.04% new Timeline SLS SELLAS LIFE SCIENCES GROUP I More: the full row for SELLAS LIFE SCIENCES GROUP I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000 $616K 0.03% new Timeline ENTA ENANTA PHARMACEUTICALS INC More: the full row for ENANTA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 29,300 shares 29,300 $386K 0.02% new Timeline QTTB Q32 BIO INC More: the full row for Q32 BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 27,777 shares; 2025Q1: 27,777 shares; 2025Q2: 27,777 shares; 2025Q3: 27,777 shares; 2025Q4: 27,777 shares; 2026Q1: 27,777 shares; 2026Q2: 27,777 shares; 2026Q3: 27,777 shares 27,777 $230K 0.01% 0 Timeline ADGM ADAGIO MED HLDGS INC More: the full row for ADAGIO MED HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 213,235 shares; 2025Q1: 213,235 shares; 2025Q2: 80,000 shares; 2025Q3: 80,000 shares; 2025Q4: 80,000 shares; 2026Q1: 80,000 shares; 2026Q2: 80,000 shares; 2026Q3: 80,000 shares 80,000 $12.2K <0.01% 0 Timeline